VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
FGNX
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
FGNXFG Nexus Inc.
$4.63$37M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksFGNXQuarterly Financials

FG Nexus Inc. (FGNX) Quarterly Financials

120+ quarters historyFree accessUpdated daily

FG Nexus Inc. (FGNX) quarterly income statement — complete revenue, gross profit & net income history

FGNX Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ1'26Q4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21
Revenue-18.43M1.08M1.45M9.09M392K-15.1M17.52M5.25M4.48M8.01M4.08M3.34M6.69M3.37M4.54M2.34M2.22M1.51M-1.2M1.84M
Revenue Growth %-4802.04%107.12%-91.73%73.21%-91.25%-288.46%329.04%57.22%-32.99%137.95%-10.14%42.63%200.76%122.31%477.81%27.12%11.43%474.07%84.36%437%
Medical Costs & Claims74K074K05.72M06.27M5.59M6.27M4.72M4.38M4.25M4.08M2.43M3.52M2.47M2.24M3.22M1.26M1.1M
Medical Cost Ratio %-0.4%0%5.11%0%1458.42%0%35.78%106.58%139.91%58.92%107.35%127.25%61.07%72.09%77.34%105.77%100.58%212.48%-104.74%59.95%
Gross Profit-18.51M1.08M1.38M9.09M-5.33M-15.1M11.25M-345K-1.79M3.29M-300K-909K2.6M940K1.03M-135K-13K-1.7M-2.46M737K
Gross Margin %100.4%100%94.89%100%-1358.42%100%64.22%-6.58%-39.91%41.08%-7.35%-27.25%38.93%27.91%22.66%-5.77%-0.58%-112.48%204.74%40.05%
Gross Profit Growth %-247.53%107.12%-87.78%2733.33%-197.82%-558.78%3850.67%62.05%-168.69%250.21%-129.13%-573.33%20123.08%155.16%141.82%-118.32%-100.71%-320.74%67.97%234.98%
Operating Expenses21.82M7.25M-2.2M3.83M3.52M-7.98M16.51M6.32M5.02M3.5M3.86M5.39M6.7M807K-9.22M5.34M3.81M1.56M1.93M297K
OpEx / Revenue %-118.36%673.79%-151.83%42.12%899.23%52.84%94.24%120.42%112.12%43.7%94.52%161.54%100.21%23.96%-202.97%228.43%171.39%103.23%-160.43%16.14%
Depreciation & Amortization74K73K74K193K188K191K184K187K267K0240K78K266K0000000
Combined Ratio %-118.76%673.79%-146.72%42.12%2357.65%52.84%130.03%227%252.03%102.62%201.86%288.79%161.28%96.05%-125.63%334.2%271.97%315.71%-265.17%76.09%
Operating Income-40.32M-6.17M3.58M5.26M-8.85M-7.12M-5.26M-6.66M-6.81M-210K-4.16M-6.3M-4.1M133K10.26M-5.48M-3.82M-3.27M-4.39M440K
Operating Margin %218.76%-573.79%246.72%57.88%-2257.65%47.16%-30.03%-127%-152.03%-2.62%-101.86%-188.79%-61.28%3.95%225.63%-234.2%-171.97%-215.71%365.17%23.91%
Operating Income Growth %-355.62%13.32%167.95%178.94%-29.94%-3291.9%-26.47%-5.76%-66.24%-257.89%-140.57%-14.97%-7.17%104.07%333.44%-1345%-3313.39%-63.48%54.19%121.45%
EBITDA-40.25M-6.1M3.65M5.45M-8.66M-6.93M-5.08M-6.47M-6.54M-210K-3.92M-6.22M-3.83M133K10.26M-5.48M-3.82M-3.27M-4.39M440K
EBITDA Margin %218.36%-567.01%251.83%60%-2209.69%45.9%-28.98%-123.43%-146.07%-2.62%-95.98%-186.45%-57.3%3.95%225.63%-234.2%-171.97%-215.71%365.17%23.91%
Interest Expense00022K33K60K66K91K142K195K121K93K111K0000000
Non-Operating Income-50K47.72M6.61M-22K-18K-463K-66K-91K-1.86M0-121K-93K-111K0000000
Pretax Income-40.27M-60.57M-3.03M5.26M-8.87M-6.72M-5.26M-6.66M-5.09M-210K-4.16M-6.3M-4.1M133K10.26M-5.48M-3.82M-3.27M-4.39M440K
Pretax Margin %218.49%-5629%-209.39%57.88%-2261.48%44.49%-30.03%-127%-113.68%-2.62%-101.86%-188.79%-61.28%3.95%225.63%-234.2%-171.97%-215.71%365.17%23.91%
Income Tax-9K-318K103K210K-68K-29K-19K-80K-17K0-306K-14K-299K0000000
Effective Tax Rate %0.02%0.53%-3.39%3.99%0.77%0.43%0.36%1.2%0.33%0%7.36%0.22%7.3%0%0%0%0%0%0%0%
Net Income-38.64M-59.07M-3.39M5.47M-9.76M-8.6M17.66M-5.78M-4.43M-210K-3.32M-5.27M-3.99M133K10.26M-5.48M-3.82M-3.36M-4.96M-227K
Net Margin %209.62%-5489.5%-234.02%60.23%-2488.52%56.97%100.78%-110.24%-98.84%-2.62%-81.32%-158.06%-59.66%3.95%225.63%-234.2%-171.97%-221.72%412.47%-12.34%
Net Income Growth %-296.08%-586.51%-119.2%194.64%-120.3%-3997.14%631.74%-9.65%-11.01%-257.89%-132.38%3.74%-4.34%103.96%306.67%-2313.22%-3344.14%-68.03%48.26%91.17%
EPS (Diluted)-582.60-22.31-1.4519.65-40.17-35.7775.30-27.30-33.56-8.06-40.01-67.92-52.92-4.18131.25-109.31-82.40-81.91-134.37-16.82
EPS Growth %-1350.34%37.63%-101.93%171.98%-19.7%-343.8%288.2%59.81%36.58%-92.82%-130.48%37.86%35.78%94.9%197.68%-549.88%-941.72%-49.8%36.27%72.05%
EPS (Basic)-582.60-22.31-1.4519.65-40.17-35.7775.30-27.30-33.56-8.06-40.01-67.92-52.92-4.18131.25-109.31-82.40-81.91-134.37-16.82
Diluted Shares Outstanding66.32K2.67M2.34M255.6K254K253K228.6K228.14K134K81.5K83K77.64K75.38K75.17K74.67K54.2K51.82K46.47K40.26K40.08K